期刊文献+
共找到102篇文章
< 1 2 6 >
每页显示 20 50 100
Cumulative live birth rates of in vitro fertilization/intracytoplasmic sperm injection after multiple complete cycles in China 被引量:1
1
作者 Lei Huang Qun Lu +16 位作者 Jiangbo Du Hong Lv Shiyao Tao Shiyao Chen Xiuzhu Li Xiumei Han Kun Zhou Bo Xu Xiaoyu Liu Hongxia Ma Yankai Xia Guangfu Jin Hongbing Shen Xiufeng Ling Zhibin Hu Jichun Tan Feiyang Diao 《The Journal of Biomedical Research》 CAS CSCD 2020年第5期361-368,I0002-I0006,共13页
There were few studies of cumulative live birth rates(CLBRs) based on multicenter reproductive clinical data from the general Chinese population.Here we report a retrospective cohort study,including 14 311 women with1... There were few studies of cumulative live birth rates(CLBRs) based on multicenter reproductive clinical data from the general Chinese population.Here we report a retrospective cohort study,including 14 311 women with17 315 cycles,in three reproductive centers to evaluate two estimated parameters of CLBRs with multiple transfer cycles of in vitro fertilization(IVF)/intracytoplasmic sperm injection(ICSI) in a Chinese population.We found that CLBRs were related to female age and endometrial thickness.By the fourth transfer cycle,the conservative and optimal estimates of CLBRs were 52.95% and 77.30% in women under 30 years of age,and 18.17% and26.51% in those 37 years of age or older,respectively.The two estimates were 44.70% and 63.15% in women with endometrial thickness more than 7 mm,and 32.05% and 46.18% in those with less than 7 mm,respectively.In addition,body mass index(BMI),duration of infertility,and infertility diagnoses may also be related to CLBRs on certain conditions.The findings from this study on CLBRs after multiple transfer cycles of IVF/ICSI treatment on different conditions in the Chinese population should be beneficial to both infertile couples and clinicians. 展开更多
关键词 cumulative live birth rate in vitro fertilization intracytoplasmic sperm injection
下载PDF
Effect of Dual Trigger In Vitro Fertilization and Intracytoplasmic Sperm Injection During the Gonadotropin-releasing Hormone-Antagonist Cycle on Final Oocyte Maturation and Cumulative Live Birth Rate in Women with Diminished Ovarian Reserve
2
作者 Yu-meng REN Yan-bin WANG +4 位作者 Min FU Qiu-xiang ZHANG Huan SHEN Hong-jing HAN Fu-mei GAO 《Current Medical Science》 SCIE CAS 2022年第5期1066-1070,共5页
Objective It is well known that a dual trigger treatment can improve clinical outcomes of in vitro fertilization(IVF)in high or normal ovarian responders.However,it is not clear whether dual triggering also benefits p... Objective It is well known that a dual trigger treatment can improve clinical outcomes of in vitro fertilization(IVF)in high or normal ovarian responders.However,it is not clear whether dual triggering also benefits patients with diminished ovarian reserve(DOR).The aim of this study was to investigate whether a dual trigger treatment of gonadotropin-releasing hormone(GnRH)agonist combined with human chorionic gonadotropin(hCG)for final follicular maturation improves the cumulative live birth rate(CLBR)during the GnRH-antagonist cycle in patients with DOR.Methods This retrospective study included patients with DOR who received a GnRH-antagonist protocol during IVF and intracytoplasmic sperm injection(IVF-ICSI)cycles at Peking University People’s Hospital from January 1,2017 through December 31,2017.Oocyte maturation was triggered by GnRH combined with hCG(n=110)or hCG alone(n=71).Embryos were transferred on the third day after oocyte retrieval or during a subsequent freeze-thaw cycle.Patients were followed up for 3 years.Results The dual trigger treatment did not affect CLBR,which is an overall determinant of the success rate of assisted reproductive technology(ART).Women in the dual trigger group had significantly higher rates of fertilization than those in the hCG group(90.1%vs.83.9%,P=0.040).Conclusion Dual trigger with GnRH agonist and hCG did not improve CLBR in patients with DOR,but did slightly improve fertilization rate,oocyte count,and embryo quality. 展开更多
关键词 dual trigger gonadotropin releasing hormone antagonist protocols diminished ovarian reserve cumulative live birth rate
下载PDF
Role of ICSI in Non-male Factor Cycles as the Number of Oocytes Retrieved Decreases from Four to One 被引量:3
3
作者 Na GUO Xiang HUA +1 位作者 Yu-feng LI Lei JIN 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2018年第1期131-136,共6页
This study aimed to investigate whether intracytoplasmic sperm injection(ICSI) shows an advantage over in vitro fertilization(IVF) in non-male factor cycles as the number of oocytes retrieved decreases from four t... This study aimed to investigate whether intracytoplasmic sperm injection(ICSI) shows an advantage over in vitro fertilization(IVF) in non-male factor cycles as the number of oocytes retrieved decreases from four to one.We undertook a retrospective analysis of 1305 IVF/ICSI cycles of non-male factor in which four or fewer oocytes were retrieved.Comparisons were made between conventional IVF(CI) and ICSI when one,two,three or four oocyte(s) were retrieved.Primary outcomes including normal fertilization rate,proportion of embryos per obtained oocyte,cycle cancellation rate,implantation rate,clinical pregnancy rate(PR),live birth rate(LBR),cumulative PR and cumulative LBR were evaluated.The results showed that the normal fertilization rate(72.5% vs.50.0%) and the proportion of embryos per obtained oocyte(72.5% vs.55.0%) were significantly increased in one oocyte retrieved cycles in ICSI group as compared with CI group.However,the proportion of embryos per obtained oocyte was markedly decreased in ICSI group when three(52.3% vs.61.3%) or four(56.9% vs.64.0%) oocytes were retrieved.The implantation rates,clinical PRs,LBRs,cumulative PRs and cumulative LBRs in CI group were comparable to those in ICSI group when one,two,three or four oocyte(s) were retrieved.In conclusion,ICSI doesn't show advantages over IVF in low oocyte yield cycles of non-male factors,even when only one oocyte was retrieved.Key words 展开更多
关键词 low oocyte yield intracytoplasmic sperm injection in vitro fertilization oocytenumber cumulative live birth rate
下载PDF
Sperm DNA fragmentation does not affect the clinical outcomes in the cumulative transfers of an ICSI cycle along with blastocyst transfers in couples with normozoospermic male patients 被引量:1
4
作者 Deepthi Repalle Saritha K.V. Shilpa Bhandari 《Asian pacific Journal of Reproduction》 2022年第3期125-131,共7页
Objective:To know whether sperm DNA fragmentation(SDF)affects the clinical outcomes in the cumulative transfers of an intracytoplasmic sperm injection(ICSI)cycle along with blastocyst transfers in couples with normozo... Objective:To know whether sperm DNA fragmentation(SDF)affects the clinical outcomes in the cumulative transfers of an intracytoplasmic sperm injection(ICSI)cycle along with blastocyst transfers in couples with normozoospermic males.Methods:The study included 252 couples who underwent their first ICSI cycles along with blastocyst transfer and whose male partner semen samples were normozoospermic according to the World Health Organization 2010 criteria.All the couples were classified into two groups based on the SDF:the low SDF group(SDF≤30%,n=162)and the high SDF group(SDF>30%,n=90).Clinical as well as laboratory outcomes were correlated between the two groups.Sperm DNA fragmentation was assessed on the post-wash semen samples by acridine orange test.The main outcome measures were the live birth rate and miscarriage rate.Results:A significant decrease in the live birth rates was observed in the high SDF group compared to the low SDF group in fresh embryo transfer cycles(P<0.05).However,no significant difference was observed in the clinical outcomes either in the frozen embryo transfer cycles or in the overall cumulative transfer cycles(P>0.05).No significant difference was observed in the laboratory outcomes between the two SDF groups.A remarkable decrease in sperm motility was observed in the high SDF group compared to the low SDF group(P<0.05).Conclusions:Sperm DNA fragmentation does not affect the clinical outcomes in the cumulative transfers of an ICSI cycle along with blastocyst transfers in couples with normozoospermic males. 展开更多
关键词 Sperm DNA fragmentation intracytoplasmic sperm injection ICSI live birth rates Blastocyst transfer cumulative transfers
下载PDF
Impact of Serum Progesterone Levels in GnRH Antagonist Assisted Reproduction Cycles on Pregnancy Outcomes: A Prospective Cohort Study
5
作者 Ahmed Abdelaziz Hytham Atia 《Open Journal of Obstetrics and Gynecology》 2019年第1期42-53,共12页
Background: With controlled ovarian hyperstimulation (COH) with gonadotrophin releasing hormone (GnRH) antagonists, sometimes it is associated with incomplete luteolysis leading to elevated serum progesterone in early... Background: With controlled ovarian hyperstimulation (COH) with gonadotrophin releasing hormone (GnRH) antagonists, sometimes it is associated with incomplete luteolysis leading to elevated serum progesterone in early follicular phase. Persistence of this elevation might reduce the chance for clinical pregnancy. Objective: To assess the effect of elevated early and late follicular progesterone (P) levels during gonadotrophins releasing hormone (GnRH) antagonist cycles on pregnancy outcome. Design: Prospective single center study. Setting: North-western Military hospital, Kingdom of Saudi Arabia. Patients: 302 in vitro fertilization/intra-cytoplasmic sperm injection (IVF-ICSI) patients. Intervention(s): Recombinant follicle stimulating hormone (r-FSH), (150 - 300 IU) started daily from cycle day 2;GnRH antagonist treatment started on day 6 of the cycle. The serum progesterone (P) measured twice on cycle day 2 and human chorionic gonadotrophin (hCG) day. Main Outcome Measures: Clinical pregnancy and live birth rates per started cycle. Results: The incidence of elevated serum P on day 2 was (5.3%) and on hCG day was (17.5%), statistically significant differences in clinical pregnancy rate (32.3% versus 13.0%) and in live birth rate (23.4% versus 11.1%) were present between the normal and high serum progesterone groups on hCG day, but these differences were not statistically significant in the groups of elevated basal progesterone. Conclusion: Follicular phase progesterone rise either on day 2 or the day of hCG trigger was associated with lower clinical pregnancy and live birth rates. This impact was more prominent with trigger day elevation. 展开更多
关键词 Elevated PROGESTERONE Clinical Pregnancy rate live birth rate GNRH ANTAGONIST cycles IVF/ICSI
下载PDF
卵巢功能减退患者多周期累积与非累积胚胎移植临床结局比较
6
作者 王宇维 王聪 +1 位作者 方颖 杨晓葵 《武警医学》 CAS 2024年第4期307-311,共5页
目的探讨卵巢功能减退(DOR)患者多周期累积与非累积胚胎移植体外受精-胚胎移植(IVF-ET)临床结局的差异。方法回顾性分析2019-01至2022-12于首都医科大学附属北京妇产医院生殖医学科进行IVF-ET治疗的卵巢储备功能减退的不孕患者174例的... 目的探讨卵巢功能减退(DOR)患者多周期累积与非累积胚胎移植体外受精-胚胎移植(IVF-ET)临床结局的差异。方法回顾性分析2019-01至2022-12于首都医科大学附属北京妇产医院生殖医学科进行IVF-ET治疗的卵巢储备功能减退的不孕患者174例的临床资料,纳入患者均已完成所有胚胎移植及最终随访。收集患者的基础内分泌、抗苗勒管激素水平及窦卵泡计数,记录促排卵治疗后的卵巢反应参数及妊娠结局等相关临床资料,比较多周期累积胚胎移植(累积组)与非累积胚胎移植(非累积组)两种IVF-ET治疗的临床结局。结果DOR患者多周期累积胚胎移植与非累积胚胎移植两组间的累积妊娠率(35.24%vs.27.54%)、早期流产率(32.43%vs.26.32%)及累积活产率(21.90%vs.18.84%)差异无统计学意义(P>0.05);纳入移植策略、BMI、首次取卵年龄、AMH、胚胎移植数、优质胚胎移植数、累积获卵数等多个因素后进行logistic回归分析,两种不同的胚胎移植策略(OR=1.522,95%CI 0.608~3.814)对活产无明显影响(P>0.05)。结论对于DOR患者,进行多周期重复取卵后的累积胚胎移植并不能提高患者的累积妊娠率及活产率。 展开更多
关键词 卵巢功能减退 累积胚胎移植 多周期累积活产率
下载PDF
Magnetic-activated cell sorting of nonapoptotic spermatozoa with a high DNA fragmentation index improves the live birth rate and decreases transfer cycles of IVF/ICSI 被引量:2
7
作者 Jie Mei Lin-Jun Chen +5 位作者 Xin-Xin Zhu Wen Yu Qing-Qiang Gao Hai-Xiang Sun Li-Jun Ding Jun-Xia Wang 《Asian Journal of Andrology》 SCIE CAS CSCD 2022年第4期367-372,共6页
The present study aimed to evaluate the clinical outcomes of magnetic-activated cell sorting(MACS)in sperm preparation for male subjects with a sperm DNA fragmentation index(DFI)≥30%.A total of 86 patients who had un... The present study aimed to evaluate the clinical outcomes of magnetic-activated cell sorting(MACS)in sperm preparation for male subjects with a sperm DNA fragmentation index(DFI)≥30%.A total of 86 patients who had undergone their first long-term long protocol were selected.The protocol involved in vitro fertilization(IVF)and intracytoplasmic sperm injection(ICSI)cycles,and the patients were divided into the MACS or control groups.The MACS group included sperm samples analyzed with MACS that were combined with density gradient centrifugation(DGC)and the swim-up(SU)technique(n=39),and the control group included sperm samples prepared using standard techniques(DGC and SU;n=41).No differences were noted with regard to basic clinical characteristics,number of oocytes retrieved,normal fertilization rate,cleavage rate,or transplantable embryo rate between the two groups in IVF/ICSI.In addition,the clinical pregnancy and implantation rates of the first embryo transfer cycles indicated no significant differences between the two groups.However,there was a tendency to improve the live birth rate(LBR)of the first embryo transfer cycle(63.2%vs 53.9%)and the cumulative LBR(79.5%vs 70.7%)in the MACS group compared with the control group.Moreover,the number of transferred embryos(mean±standard deviation[s.d.]:1.7±0.7 vs 2.3±1.6)and the transfer number of each retrieved cycle(mean±s.d.:1.2±0.5 vs 1.6±0.8)were significantly lower in the MACS group than those in the control group.Thus,the selection of nonapoptotic spermatozoa by MACS for higher sperm DFI could improve assisted reproductive clinical outcomes. 展开更多
关键词 cumulative live birth rate fertility rate intracytoplasmic sperm injection sperm DNA fragmentation index sperm DNA integrity
原文传递
Analysis of related factors affecting cumulative live birth rates of the first ovarian hyperstimulation in vitro fertilization or intracytoplasmic sperm injection cycle: a population-based study from 17,978 women in China 被引量:2
8
作者 Rui Yang Zi-Ru Niu +3 位作者 Li-Xue Chen Ping Liu Rong Li Jie Qiao 《Chinese Medical Journal》 SCIE CAS CSCD 2021年第12期1405-1415,共11页
Background:More and more scholars have called for the cumulative live birth rate(CLBR)of a complete ovarian stimulation cycle as a key indicator for assisted reproductive technology.This research aims to study the CLB... Background:More and more scholars have called for the cumulative live birth rate(CLBR)of a complete ovarian stimulation cycle as a key indicator for assisted reproductive technology.This research aims to study the CLBR of the first ovarian hyperstimulation cycles and analyze the related prognosis factors that might affect the CLBR.Methods:Our retrospective study included first in vitro fertilization or intracytoplasmic sperm injection(IVF/ICSI)cycles performed between January 2013 to December 2014.A total of 17,978 couples of first ovarian hyperstimulation IVF/ICSI cycles were included.The study was followed up for 4 years to observe the CLBR.The multivariable logistic regression model was used to analyze the prognosis factor,P value of<0.05 was considered statistically significant.Results:The cumulative pregnancy rate was 58.14%(10,452/17,978),and the CLBR was 49.66%(8928/17,978).The female age was younger in the live birth group when compared with the non-live birth group(30.81±4.05 vs.33.09±5.13,P<0.001).The average duration of infertility was shorter than the non-live birth cohort(4.22±3.11 vs.5.06±4.08,P<0.001).The preliminary gonadotropin used and the total number of gonadotropin used were lower in the live birth group when compared with the non-live birth group(both P<0.001).Meanwhile,the number of oocytes retrieved and transferrable embryos were both significantly higher in the live birth group(15.35±7.98 vs.11.35±7.60,P<0.001;6.66±5.19 vs.3.62±3.51,P<0.001,respectively).Conclusions:The women's age,body mass index,duration of infertility years,infertility factors,controlled ovarian hyperstimulation protocol,the number of acquired oocytes,and number of transferrable embryos are the prognosis factors that significantly affected the CLBR. 展开更多
关键词 cumulative live birth rates IVF ICSI Controlled ovarian hyperstimulation in vitro fertilization intracytoplasmic sperm injection
原文传递
Prediction of Cumulative Live Birth Rate in Women Aged 40 Years and Over Undergoing In vitro Fertilization/Intracytoplasmic Sperm Injection 被引量:2
9
作者 Jia Lei Chen Pan-Yu +4 位作者 Guo Ying-Chun Zhang Zhi-Qiang Gong Xiao Chen Jing-Bo Fang Cong 《Reproductive and Developmental Medicine》 CSCD 2020年第4期233-238,共6页
Objective:To investigate cumulative live birth rate (cLBR) per oocyte retrieval in infertile patients aged 40 years and over undergoing their first in vitro fertilization/intracytoplasmic sperm injection cycles and to... Objective:To investigate cumulative live birth rate (cLBR) per oocyte retrieval in infertile patients aged 40 years and over undergoing their first in vitro fertilization/intracytoplasmic sperm injection cycles and to identify the possible predictors.Methods:A total of 1,613 patients at a university hospital in China from January 2013 to May 2017 were enrolled in this retrospective study.All data for fresh and subsequent frozen-thawed cycles were analyzed.Multivariate logistic regression analysis with stepwise selection of possible predictors for cLBR was performed,and Loess curve was constructed to determine the association between cLBR and the number of oocytes retrieved.Results:cLBR significantly increased with the number of oocytes retrieved and reached up to 75% when > 20 oocytes were retrieved (P<0.001).Variables of antral follicle count (AFC) and the number of oocytes retrieved were selected using multiple logistic regression analysis with stepwise selection to predict the significance of cLBR.cLBR demonstrated an obvious upward trend as the number of oocytes retrieval increased in the Loess curve.Conclusions:For patients aged 40 years and over,AFC and the number of oocytes retrieved were two key predictors for cLBR and maximization of ovarian reserve exploitation was pivotal to increase the chance of live birth. 展开更多
关键词 Advanced Maternal Age cumulative live birth rate in vitro Fertilization Number of Oocytes Retrieved
原文传递
IVF/ICSI-ET中胚胎实时监测系统与常规形态学评估选择性单胚胎移植累积活产率分析
10
作者 成桂红 郑爱燕 +7 位作者 丁洁 邹琴燕 许咏乐 朱蕊 王馥新 吴惠华 李红 孟庆霞 《实用妇产科杂志》 CAS CSCD 北大核心 2024年第2期130-135,共6页
目的:分析胚胎实时监测(TLM)系统和常规形态学评估(CMA)在体外受精/卵胞浆内单精子注射-胚胎移植(IVF/ICSI-ET)中选择性单胚胎移植的临床应用价值,并初步探讨拉曼光谱分析胚胎培养液对临床妊娠率的预测价值。方法:本研究为前瞻性随机对... 目的:分析胚胎实时监测(TLM)系统和常规形态学评估(CMA)在体外受精/卵胞浆内单精子注射-胚胎移植(IVF/ICSI-ET)中选择性单胚胎移植的临床应用价值,并初步探讨拉曼光谱分析胚胎培养液对临床妊娠率的预测价值。方法:本研究为前瞻性随机对照临床研究,选择2019年4月至2020年7月在苏州市立医院生殖与遗传中心行IVF/ICSI-ET助孕的139例患者,随机分为TLM组和CMA组,分别选择最优胚胎行单胚胎移植(新鲜周期和复苏周期),患者第1次胚胎移植未获临床妊娠,则进行第2次,比较两组患者移植后的累积活产率和其他妊娠结局差异。同时收集IVF/ISCI受精后第3天胚胎培养液15μl,进行拉曼光谱分析。结果:TLM组与CMA组的累积活产率、累积临床妊娠率、累积早产率、累积早期自然流产率、累积异位妊娠率、累积早产率、小于胎龄儿或大于胎龄儿差异均无统计学意义(P>0.05)。TLM组新生儿性别比低于CMA组,但差异无统计学意义(P>0.05)。胚胎培养液拉曼光谱分析预测临床妊娠率的准确度为67.21%。结论:在卵巢储备功能良好的年轻女性中,进行选择性单胚胎移植时TLM评估胚胎优势不明显,需警惕基于动力学参数的胚胎选择可能影响性别比。拉曼光谱分析胚胎培养液尚不能很好地预测胚胎的种植能力。 展开更多
关键词 体外受精/卵胞浆内单精子注射-胚胎移植 胚胎实时监测 常规形态学 拉曼光谱分析 累积活产率
下载PDF
不同国家与地区辅助生殖临床数据特征的比较分析 被引量:2
11
作者 郑永杰 董杰 《生殖医学杂志》 CAS 2024年第2期187-193,共7页
目的通过比较我国与欧盟、美国、日本、澳大利亚与新西兰、拉丁美洲公开的2018年辅助生殖技术(ART)数据,了解不同国家与地区的ART助孕周期数、人群特点、ART助孕原因及助孕结局。方法搜集我国与欧盟、美国、日本、澳大利亚与新西兰、拉... 目的通过比较我国与欧盟、美国、日本、澳大利亚与新西兰、拉丁美洲公开的2018年辅助生殖技术(ART)数据,了解不同国家与地区的ART助孕周期数、人群特点、ART助孕原因及助孕结局。方法搜集我国与欧盟、美国、日本、澳大利亚与新西兰、拉丁美洲已公布的2018年ART数据,比较不同ART类型的治疗周期数、接受ART治疗的病因、女性年龄情况、临床妊娠率、活产率、多胎率及单胚胎移植占比等。结果不同于其他国家与地区,我国ICSI周期数明显少于IVF周期数;我国和日本的冻融胚胎移植(FET)周期数明显多于新鲜周期。我国不孕不育夫妇进行ART治疗的主要原因是输卵管因素和男方因素,分别占47.90%和31.70%。我国接受ART治疗的女性中,大部分年龄小于<35岁,占ART治疗总人数的64%;而日本有51%接受ART治疗的女性年龄>40岁。相较于其他国家或地区,我国与美国的ART鲜胚移植周期与FET周期的临床妊娠率与活产率较高。我国的ART多胎率明显高于其他国家或地区,而单胚胎移植比例相对较低。结论2018年我国不同类型的ART治疗周期、不孕女性年龄及不孕原因与其他国家或地区不同,虽然我国ART治疗成功率较高但多胎率也较高,需要进一步优化ART移植策略。 展开更多
关键词 辅助生殖技术 国家 地区 临床妊娠率 活产率 多胎率
下载PDF
卵泡期与黄体期长方案鲜胚移植周期活产率和累积活产率比较
12
作者 郑娟 胡巨伟 周黎明 《生殖医学杂志》 CAS 2024年第5期599-604,共6页
目的比较卵泡期长方案与黄体期长效长方案促排卵后鲜胚移植周期的活产率和每取卵周期累积活产率,探讨两种垂体降调节方案的优劣势。方法回顾性分析2018年1月至2021年12月间于宁波大学附属妇女儿童医院生殖中心行体外受精-胚胎移植(IVF-... 目的比较卵泡期长方案与黄体期长效长方案促排卵后鲜胚移植周期的活产率和每取卵周期累积活产率,探讨两种垂体降调节方案的优劣势。方法回顾性分析2018年1月至2021年12月间于宁波大学附属妇女儿童医院生殖中心行体外受精-胚胎移植(IVF-ET)治疗、采用卵泡期长方案或黄体期长效长方案促排、卵巢储备功能正常患者的临床资料(共1969个周期),并根据促排卵方案不同分为卵泡期组(使用卵泡期长方案促排卵,461个周期)和黄体期组(使用黄体期长效长方案促排卵,1508个周期)。比较两组患者的一般情况及临床结局。结果两组患者的女性年龄、不孕年限、体质量指数(BMI)、抗苗勒管激素(AMH)水平、不孕原因等一般资料比较均无显著性差异(P>0.05)。卵泡期组的Gn天数显著高于黄体期组[(11.0±3.3)d vs.(10.6±3.1)d](P<0.01),Gn总剂量显著低于黄体期组[(2390.9±331.3)U vs.[(2645.5±308.1)U](P<0.01)。两组患者的优势卵泡数、获卵数及可利用胚胎数比较均无显著性差异(P>0.05)。卵泡期组HCG日E 2、LH及P水平均显著低于黄体期组(P<0.01)。两组患者的移植日内膜厚度、移植胚胎数比较均无显著性差异(P>0.05)。卵泡期组鲜胚移植周期活产率略低于黄体期组(44.81%vs.49.34%),差异尚无统计学意义(P=0.26)。卵泡期组的中重度卵巢过度刺激综合征(OHSS)发生率(0.87%vs.1.59%)及每取卵周期累计活产率(68.11%vs.70.76%)均略低于黄体期组,但差异尚无统计学意义(P>0.05)。结论对于卵巢储备功能正常的女性,使用卵泡期长方案促排卵可获得与黄体期长方案相似的临床结局。 展开更多
关键词 控制性促排卵 体外受精-胚胎移植 活产率 累积活产率
下载PDF
大于38岁女性冻融移植周期单囊胚与双囊胚移植妊娠结局比较
13
作者 何毅超 郑炜炜 +1 位作者 林盛 祝晓丽 《生殖医学杂志》 CAS 2024年第4期435-440,共6页
目的探讨大于38岁女性在冻融囊胚移植周期中移植不同囊胚数目和质量时的妊娠结局。方法纳入2017年1月至2021年12月在广东省生殖医院生殖中心接受冻融囊胚移植且移植年龄大于38岁的249例女性为研究对象,对其249个移植周期的临床资料进行... 目的探讨大于38岁女性在冻融囊胚移植周期中移植不同囊胚数目和质量时的妊娠结局。方法纳入2017年1月至2021年12月在广东省生殖医院生殖中心接受冻融囊胚移植且移植年龄大于38岁的249例女性为研究对象,对其249个移植周期的临床资料进行回顾性分析。根据不同的囊胚移植数目和质量分为5组:移植单个优质囊胚组(A组,94个周期),移植单个非优质囊胚组(B组,103个周期),移植双优质囊胚组(C组,10个周期),移植单个优质囊胚+单个非优质囊胚组(D组,18个周期)和移植双非优质囊胚组(E组,24个周期)。比较分析不同囊胚移植数目和质量组间的一般资料、胚胎实验室指标及妊娠结局。结果各组患者的一般情况比较发现,D组的取卵年龄显著大于A组(P<0.05),C组的基础FSH(bFSH)显著低于A组,E组的bFSH显著低于B组(P均<0.05);各组间移植年龄、窦卵泡数、体质量指数(BMI)、促性腺激素(Gn)用量、移植日内膜厚度、人工周期方案比例均无显著性差异(P>0.05)。E组的获卵数显著大于B组[(12.67±4.98)vs.(10.69±4.08),P<0.05];各组间D3可用胚胎数、优胚数、囊胚培养数、囊胚形成数、囊胚冷冻数比较均无显著性差异(P>0.05)。A组与C组比较,多胎率显著降低(6.00%vs.33.30%,P<0.05),组间着床率、临床妊娠率、流产率、活产率及早产率比较均无显著性差异(P>0.05);A组与D组比较,着床率显著增高(53.20%vs.27.80%,P<0.05),活产率相似(35.10%vs.33.30%,P>0.05);A组与E组比较,多胎率显著降低(6.00%vs.33.30%,P<0.05),组间着床率、临床妊娠率、流产率、早产率、活产率比较均无显著性差异(P>0.05);B组与E组比较,临床妊娠率、多胎率显著降低(P<0.05),组间着床率、流产率、活产率及早产率比较均无显著性差异(P>0.05)。结论大于38岁高龄女性在冻融囊胚移植周期中若有优质囊胚,建议优先移植单个优质囊胚;若没有优质囊胚,也应考虑移植单个囊胚。 展开更多
关键词 高龄 囊胚移植 多胎率 活产率
下载PDF
血清AMH对早卵泡期长效长方案促排下IVF/ICSI-ET患者的影响
14
作者 苏杨 谢辉奕 郑文为 《中外医学研究》 2024年第29期1-6,共6页
目的:探讨血清抗米勒管激素(AMH)对早卵泡期长效长方案促排下IVF/卵胞质内单精子注射(ICSI)-ET患者的影响。方法:回顾性选取2017年1月—2021年12月泉州市妇幼保健院·儿童医院生殖医学中心收治的740例早卵泡期长效长方案促排IVF/ICS... 目的:探讨血清抗米勒管激素(AMH)对早卵泡期长效长方案促排下IVF/卵胞质内单精子注射(ICSI)-ET患者的影响。方法:回顾性选取2017年1月—2021年12月泉州市妇幼保健院·儿童医院生殖医学中心收治的740例早卵泡期长效长方案促排IVF/ICSI-ET患者。所有患者均进行早卵泡期长效长方案促排。收集所有患者一般资料。比较三组一般资料、胚胎情况、新鲜移植周期妊娠结局、累积妊娠率及活产率。结果:随着AMH水平升高,原发不孕占比升高,基础促卵泡生成素(FSH)水平和年龄降低,差异有统计学意义(P<0.05)。随着AMH水平的升高,扳机日雌二醇(E2)水平及≥14 mm卵泡数增加,促性腺激素(Gn)启动量、Gn总量降低,差异有统计学意义(P<0.05)。随着AMH水平的升高,平均获卵数、囊胚形成率及可利用囊胚形成率均升高,差异有统计学意义(P<0.05)。随着AMH水平的降低,新鲜移植周期的临床妊娠率和活产率有降低趋势,异位妊娠率有升高的趋势,差异无统计学意义(P>0.05)。随着AMH水平的升高,累积妊娠率和累积活产率均升高,差异有统计学意义(P<0.05)。结论:早卵泡长效长方案中,高水平的AMH有利于IVF/ICSI周期的卵母细胞获得及囊胚形成,从而提高累积妊娠率和累积活产率。 展开更多
关键词 抗米勒管激素 早卵泡期长效长方案 胚胎质量 累积活产率
下载PDF
长效GnRH激动剂与GnRH拮抗剂促排卵方案在反复种植失败患者中的临床应用 被引量:1
15
作者 李婷婷 陈攀宇 +4 位作者 刘晓娉 杨星 王艳芳 梁晓燕 黄睿 《生殖医学杂志》 CAS 2023年第5期652-658,共7页
目的 比较卵泡期长效促性腺激素释放激素(GnRH)激动剂方案和GnRH拮抗剂方案应用于反复种植失败(RIF)患者的临床效果。方法 回顾性分析2017年6月至2020年3月在中山大学附属第六医院生殖医学中心行体外受精/卵胞浆内单精子注射(IVF/ICSI)... 目的 比较卵泡期长效促性腺激素释放激素(GnRH)激动剂方案和GnRH拮抗剂方案应用于反复种植失败(RIF)患者的临床效果。方法 回顾性分析2017年6月至2020年3月在中山大学附属第六医院生殖医学中心行体外受精/卵胞浆内单精子注射(IVF/ICSI)治疗的RIF患者的临床资料。根据促排卵方案进行分组,并通过倾向性评分1∶1匹配选择数据,最终纳入594例患者,长效激动剂组(采用长效GnRH激动剂方案促排卵)297例,拮抗剂组(采用GnRH拮抗剂方案促排卵)297例。比较两组患者的一般资料、促排卵及胚胎发育情况、鲜胚移植及冻融胚胎移植妊娠结局。结果 两组患者的年龄、不孕年限、基础激素水平等一般资料比较均无显著性差异(P>0.05)。拮抗剂组HCG日LH水平显著高于长效激动剂组(P<0.05),HCG日子宫内膜厚度、Gn总量、Gn天数、获卵数则显著低于长效激动剂组(P<0.05)。长效激动剂组新鲜周期的临床妊娠率、活产率显著高于拮抗剂组(P<0.05),两组患者冷冻周期的妊娠结局无显著性差异(P>0.05);但长效激动剂组的累计活产率显著高于拮抗剂组(P<0.05)。结论 卵泡期长效激动剂方案促排卵后行新鲜周期移植的助孕策略可以显著改善RIF患者的妊娠结局,值得优先考虑。 展开更多
关键词 反复种植失败 卵巢刺激 长效促性腺激素释放激素激动剂 促性腺激素释放激素拮抗剂 累计活产率
下载PDF
桑椹胚移植在体外受精-胚胎移植中的临床应用
16
作者 孙庆云 王跃 +4 位作者 朱序理 周亮 杜元杰 曹金凤 郝桂敏 《现代妇产科进展》 北大核心 2023年第9期678-682,共5页
目的:探讨新鲜周期day4(D4)桑椹胚移植的可行性和移植策略。方法:回顾分析2013年1月至2021年12月在河北医科大学第二医院生殖医学中心行IVF/ICSI-ET的day3(D3)和D4新鲜周期移植患者的临床资料。D4桑椹胚移植205周期,采用倾向性评分(PSM)... 目的:探讨新鲜周期day4(D4)桑椹胚移植的可行性和移植策略。方法:回顾分析2013年1月至2021年12月在河北医科大学第二医院生殖医学中心行IVF/ICSI-ET的day3(D3)和D4新鲜周期移植患者的临床资料。D4桑椹胚移植205周期,采用倾向性评分(PSM)1∶4匹配,D3移植组820周期,比较两组总的临床妊娠率、胚胎种植率、流产率、活产率及出生缺陷情况。比较D4移植双胚、单胚不同评级桑椹胚患者妊娠结局。比较D41~2级单桑椹胚移植和D5/D6单囊胚移植患者妊娠结局。结果:D3、D4移植两组患者的临床妊娠率、种植率、多胎率、异位妊娠率、流产率、活产率以及出生缺陷率比较,差异均无统计学意义(P>0.05)。按D4移植的桑椹胚评级分组,移植1~2级桑椹胚组的种植率显著高于移植3级桑椹胚组患者,差异有统计学意义(P<0.05)。D4移植一枚1~2级桑椹胚患者与D5/D6单囊胚移植患者的临床妊娠率和活产率比较,差异均无统计学意义(P>0.05)。结论:D4桑椹胚移植的策略是可行的,其增加了胚胎选择方案,是移植策略的有效补充;优质的单桑椹胚胎移植在保证较好的临床妊娠率和活产率的前提下降低多胎率;桑椹胚移植既对胚胎进行了优选又缩短了胚胎在体外的培养时间。 展开更多
关键词 桑椹胚移植 新鲜周期 临床妊娠 胚胎种植率 活产率
下载PDF
剖宫产史对IVF/ICSI-ET治疗累积活产率的影响
17
作者 姚汝强 王昕妍 +3 位作者 刁俊荣 张星星 张云山 罗海宁 《国际生殖健康/计划生育杂志》 CAS 2023年第3期177-183,共7页
目的:比较既往剖宫产患者与既往阴道分娩患者接受体外受精/卵胞质内单精子注射-胚胎移植(in vitro fertilization/intracytoplasmic sperm injection-embryo transfer,IVF/ICSI-ET)治疗首个取卵周期的临床结局。方法:回顾性分析2015年1... 目的:比较既往剖宫产患者与既往阴道分娩患者接受体外受精/卵胞质内单精子注射-胚胎移植(in vitro fertilization/intracytoplasmic sperm injection-embryo transfer,IVF/ICSI-ET)治疗首个取卵周期的临床结局。方法:回顾性分析2015年1月—2020年12月在天津市中心妇产科医院生殖医学中心行首次IVF/ICSI-ET治疗且既往有1次分娩史的患者既往剖宫产史对一次取卵周期累积活产率(cumulative live birth rate,CLBR)的影响。结果:共纳入1216例患者,其中既往剖宫产者605例共1053个移植周期,既往阴道分娩者611例共947个移植周期。2组患者除基础泌乳素与不孕时间外的主要基本特征、促排卵治疗方案、获卵情况、胚胎实验室结局差异均无统计学意义(均P>0.05)。既往剖宫产组单胚胎移植周期、冻融胚胎移植周期比例更高(P<0.05)。既往剖宫产组一次取卵后CLBR为59.00%(95%CI:55.08%~62.92%),既往阴道分娩组一次取卵后CLBR为62.68%(95%CI:58.84%~66.51%),2组比较差异有统计学意义(χ^(2)=13.665,P<0.001)。校正年龄、获卵数、胚胎质量及子宫内膜厚度后,与既往阴道分娩患者相比,既往剖宫产患者一次取卵后CLBR的OR值为0.825(95%CI:0.712~0.956,χ^(2)=6.531,P=0.011)。结论:与既往阴道分娩患者相比,既往剖宫产患者接受IVF/ICSI-ET治疗后,一次取卵周期的CLBR更低。 展开更多
关键词 剖宫产 体外受精 精子注射 细胞质内 累积活产率 回顾性研究 队列研究
下载PDF
两种子宫内膜准备方案对月经周期不规则患者冻融胚胎移植妊娠结局的影响 被引量:1
18
作者 黄剑云 胡欣叶 +4 位作者 焦雪丹 邱绮 梁怡婳 林海燕 张清学 《生殖医学杂志》 CAS 2023年第4期487-492,共6页
目的探讨激素替代周期方案和促排卵方案准备内膜,对月经不规则患者冻融胚胎移植(FET)助孕结局的影响。方法采用前瞻性随机对照研究方法,选取2010年1月至2017年12月于中山大学孙逸仙纪念医院生殖中心行FET的月经不规则、年龄≤40岁、可... 目的探讨激素替代周期方案和促排卵方案准备内膜,对月经不规则患者冻融胚胎移植(FET)助孕结局的影响。方法采用前瞻性随机对照研究方法,选取2010年1月至2017年12月于中山大学孙逸仙纪念医院生殖中心行FET的月经不规则、年龄≤40岁、可利用冷冻胚胎≥3的192例患者。将患者随机分为激素替代周期组(HRT组,n=105)和促排卵方案组(OI组,n=87)。比较两组患者的一般资料、临床结局以及新生儿出生情况。结果HRT组和OI组的活产率分别为36.19%和44.83%,组间比较无统计学差异(P>0.05);两组间临床妊娠率、胚胎种植率、早期流产率、晚期流产率、多胎妊娠率、早产率、低出生体重儿率比较均无统计学差异差异(P>0.05)。OI组的内膜厚度[10.00(9.00,11.00)mm]显著大于HRT组[8.40(8.00,9.10)mm](P<0.05)。结论对于月经不规则患者FET周期,HRT方案与OI方案准备内膜的妊娠结局相当。 展开更多
关键词 冻融胚胎移植 内膜准备方案 激素替代周期 促排卵方案 活产率
下载PDF
激动剂方案和拮抗剂方案对波塞冬组1人群的疗效分析
19
作者 顾小铃 陈艳男 +2 位作者 王青欣 王迪 王霞 《实用妇产科杂志》 CAS CSCD 北大核心 2023年第12期934-938,共5页
目的:评估促性腺激素释放激素激动剂(GnRH-a)方案和促性腺激素释放激素拮抗剂(GnRH-ant)方案在波塞冬(POSEIDON)组1人群中的疗效。方法:回顾性分析2019年1月至2020年12月在南通大学附属医院生殖医学中心行辅助生殖助孕的POSEIDON组1患者... 目的:评估促性腺激素释放激素激动剂(GnRH-a)方案和促性腺激素释放激素拮抗剂(GnRH-ant)方案在波塞冬(POSEIDON)组1人群中的疗效。方法:回顾性分析2019年1月至2020年12月在南通大学附属医院生殖医学中心行辅助生殖助孕的POSEIDON组1患者399例。采用1∶1倾向性评分匹配(PSM)筛选具有相似基线特征的队列,比较GnRH-a方案组和GnRH-ant方案组患者的基线资料、临床及实验室指标和临床结局。结果:①100例行GnRH-a方案的患者和100例行GnRH-ant方案的患者形成匹配。②GnRH-a方案组的促性腺激素(Gn)使用总量和Gn总使用时间均高于GnRH-ant方案组(P<0.001,P=0.048),绒促性素(HCG)注射日的激素水平(黄体生成素、雌二醇、孕酮)均低于GnRH-ant方案组(P<0.001,P=0.011,P<0.001),两组间卵泡数差异无统计学意义(P>0.05);GnRH-a方案组获卵数、成熟卵子数、正常受精数、优质胚胎数和可利用胚胎数均低于GnRH-ant方案组(P<0.01)。③GnRH-a方案组的到达活产时间(TTLB)高于GnRH-ant方案组(P=0.005),累积活产率(CLBR)低于GnRH-ant方案组(P=0.048),两组间移植次数(P=0.536)、累积妊娠率(P=0.084)无统计学差异。④GnRH-a方案组到达活产的经济花费高于GnRH-ant方案组(P=0.02)。结论:与GnRH-a方案相比,GnRH-ant方案可改善POSEIDON组1患者的单次促排卵周期的CLBR,并可缩短患者TTLB,降低患者的治疗成本,是POSEIDON组1患者的优选方案。 展开更多
关键词 累积活产率 累积妊娠率 促性腺激素释放激素激动剂 促性腺激素释放激素拮抗剂 波塞冬标准
下载PDF
长方案促排卵晚卵泡期孕酮升高对胚胎质量及累积活产率的影响
20
作者 李丹阳 张亚 +7 位作者 董孝贞 徐影 杨如雪 黄江笛 张俊韦 胡继君 管一春 孙丽君 《现代妇产科进展》 北大核心 2023年第8期595-599,共5页
目的:探讨早卵泡期长效长方案与黄体中期长效长方案促排卵晚卵泡期孕酮(P)升高对体外受精或卵胞浆内单精子注射(IVF/ICSI)助孕患者的胚胎质量及累积活产率的影响。方法:回顾分析2015年10月至2021年12月在郑州大学第三附属医院生殖中心... 目的:探讨早卵泡期长效长方案与黄体中期长效长方案促排卵晚卵泡期孕酮(P)升高对体外受精或卵胞浆内单精子注射(IVF/ICSI)助孕患者的胚胎质量及累积活产率的影响。方法:回顾分析2015年10月至2021年12月在郑州大学第三附属医院生殖中心行长方案促排卵的7001个周期的临床资料,依据HCG日血清P值分为两组,低孕酮组HCG日P<2.0ng/mL,高孕酮组HCG日P≥2.0ng/mL。采用线性回归与logistic回归分析校正混杂因素比较两组患者促排卵周期的实验室指标、首个胚胎移植周期的临床结局及累积活产率。结果:线性回归分析结果显示,高孕酮组的可利用胚胎率(β=-0.024,95%CI为-0.040~-0.009,P=0.002)、囊胚形成率(β=-0.067,95%CI为-0.093~-0.041,P<0.001)和首个胚胎移植周期的种植率(β=-0.078,95%CI为-0.114~-0.041,P<0.001)均显著低于低孕酮组。Logistic回归分析结果显示,高孕酮组首个胚胎移植周期的临床妊娠率(aOR=0.693,95%CI为0.579~0.829,P<0.001)、多胎妊娠率(aOR=0.622,95%CI为0.426~0.908,P=0.014)、活产率(aOR=0.624,95%CI为0.524~0.744,P<0.001)和累积活产率(aOR=0.587,95%CI为0.416~0.828,P=0.002)亦显著低于低孕酮组,而早期流产率(aOR=1.728,95%CI为1.217~2.455,P=0.002)与晚期流产率(aOR=2.045,95%CI为1.042~4.016,P=0.038)则显著高于低孕酮组。Logistic多元逐步回归分析结显示,晚卵泡期P提前上升的相关因素为年龄、抗苗勒管激素、促性腺激素总量、获卵数、HCG日黄体生成素水平和HCG日雌二醇水平。结论:长方案促排卵晚卵泡期P升高可能对患者的胚胎质量有负面影响,进而影响其累积活产率。在控制性超促排卵过程中,控制患者的促排卵药物剂量及获卵数,可减少因孕酮升高而对IVF/ICSI结局带来的不利影响。 展开更多
关键词 晚卵泡期 孕酮 胚胎质量 累积活产率 早卵泡期长效长方案 黄体中期长效长方案
下载PDF
上一页 1 2 6 下一页 到第
使用帮助 返回顶部